<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=379649259166033&amp;ev=PageView&amp;noscript=1">


PROTAC — Developing New Therapies through Targeted Protein Degradation

Wednesday, March 11th at 9AM (PT), 12-noon (ET) and 16:00 (GMT) 

A new technology that takes advantage of the natural machinery of the cell to degrade proteins instead of simply inhibiting their activity

Join CDD and our panel of experts as we take a look at the promise of PROteolysis TArgeting Chimera just as the first PROTACs are going through clinical trials!

Andy-Phillips-200px Eric-Fischer-200px Nathanael-Gray-200px
Andy Phillips, PhD
C4 Therapeutics
Eric Fischer, PhD
Harvard Medical School
Nathanael Gray, PhD
Harvard Medical School

The discussion will focus on:

  • How we can co-opt ubiquitination and the proteasome to treat diseases? 
  • What diseases are good candidates for PROTACS and why?
  • How technology developments are impacting PROTAC strategies?

Enter your email address to reserve your FREE webinar seat now. 

Reserve Your Webinar Seat: